158 related articles for article (PubMed ID: 15544498)
1. Cellular and molecular effects of macrolides on leukocyte function.
Labro MT
Curr Pharm Des; 2004; 10(25):3067-80. PubMed ID: 15544498
[TBL] [Abstract][Full Text] [Related]
2. Macrolide antibiotics: current and future uses.
Labro MT
Expert Opin Pharmacother; 2004 Mar; 5(3):541-50. PubMed ID: 15013923
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Development of Macrolide Antibiotics as Antimicrobial Agents.
Qin Y; Ma S
Mini Rev Med Chem; 2020; 20(7):601-625. PubMed ID: 31868146
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions].
Azuma A
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):376-85. PubMed ID: 15768605
[No Abstract] [Full Text] [Related]
5. International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
File TM; Tan JS
Drugs; 2003; 63(2):181-205. PubMed ID: 12515565
[TBL] [Abstract][Full Text] [Related]
6. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
[TBL] [Abstract][Full Text] [Related]
7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
9. Macrolides in cystic fibrosis.
Bell SC; Senini SL; McCormack JG
Chron Respir Dis; 2005; 2(2):85-98. PubMed ID: 16279156
[TBL] [Abstract][Full Text] [Related]
10. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics.
Steel HC; Theron AJ; Cockeran R; Anderson R; Feldman C
Mediators Inflamm; 2012; 2012():584262. PubMed ID: 22778497
[TBL] [Abstract][Full Text] [Related]
11. The role of macrolides in asthma: current evidence and future directions.
Wong EH; Porter JD; Edwards MR; Johnston SL
Lancet Respir Med; 2014 Aug; 2(8):657-70. PubMed ID: 24948430
[TBL] [Abstract][Full Text] [Related]
12. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.
Sharma S; Jaffe A; Dixon G
Paediatr Drugs; 2007; 9(2):107-18. PubMed ID: 17407366
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of macrolides in childhood lung diseases.
Luisi F; Gandolfi TD; Daudt AD; Sanvitto JP; Pitrez PM; Pinto LA
J Bras Pneumol; 2012; 38(6):786-96. PubMed ID: 23288126
[TBL] [Abstract][Full Text] [Related]
15. New macrolides.
Dalziel C; Turner B
IDrugs; 2006 Nov; 9(11):771-3. PubMed ID: 17096297
[No Abstract] [Full Text] [Related]
16. Clinical implications of the immunomodulatory effects of macrolides.
Tamaoki J; Kadota J; Takizawa H
Am J Med; 2004 Nov; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of macrolides in the lung: lessons from in-vitro and in-vivo models.
Tsai WC; Standiford TJ
Curr Pharm Des; 2004; 10(25):3081-93. PubMed ID: 15544499
[TBL] [Abstract][Full Text] [Related]
18. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
19. Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis.
Munić V; Banjanac M; Koštrun S; Nujić K; Bosnar M; Marjanović N; Ralić J; Matijašić M; Hlevnjak M; Eraković Haber V
Pharmacol Res; 2011 Sep; 64(3):298-307. PubMed ID: 21473915
[TBL] [Abstract][Full Text] [Related]
20. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
Eraković Haber V; Bosnar M; Kragol G
Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
